Sinovac Biotech Ltd financial data

Symbol
SVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
No. 39 Shangdi Xi Road, Haidian District, Beijing, China
State of incorporation
Antigua And Barbuda
Fiscal year end
December 31
Former names
NET FORCE SYSTEMS INC (to 1/13/2004)
Latest financial report
Q4 2023 - Apr 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin -135 % -331%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.6M shares +0.14%
Common Stock, Shares, Outstanding 99.6M shares +0.14%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 99.6M shares +0.11%
Weighted Average Number of Shares Outstanding, Diluted 99.6M shares -12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 448M USD -70%
Cost of Revenue 182M USD -73.5%
Research and Development Expense 345M USD -22.1%
Operating Income (Loss) -603M USD -29.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -153M USD -706%
Income Tax Expense (Benefit) 105M USD
Net Income (Loss) Attributable to Parent -99.9M USD -188%
Earnings Per Share, Basic -1.06 USD/shares -198%
Earnings Per Share, Diluted -1.06 USD/shares -206%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.27B USD -70.3%
Accounts Receivable, after Allowance for Credit Loss, Current 440M USD -18.1%
Inventory, Net 140M USD -22.6%
Assets, Current 11.8B USD -2.44%
Deferred Income Tax Assets, Net 29.8M USD -58.1%
Property, Plant and Equipment, Net 980M USD -1.43%
Operating Lease, Right-of-Use Asset 45.5M USD -22.3%
Intangible Assets, Net (Excluding Goodwill) 8.52M USD -12.2%
Other Assets, Noncurrent 7.35M USD +163%
Assets 13.7B USD -3.24%
Employee-related Liabilities, Current 644M USD +107%
Accrued Liabilities, Current 251M USD +3.31%
Liabilities, Current 1.15B USD +5.16%
Deferred Income Tax Liabilities, Net 264M USD +9.19%
Operating Lease, Liability, Noncurrent 39.3M USD -25.2%
Other Liabilities, Noncurrent 439K USD +82.9%
Liabilities 1.64B USD +16.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -490M USD -27.9%
Retained Earnings (Accumulated Deficit) 7.12B USD -1.49%
Stockholders' Equity Attributable to Parent 8.71B USD -2.38%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 12B USD -5.43%
Liabilities and Equity 13.7B USD -3.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 104M USD
Net Cash Provided by (Used in) Financing Activities -76.1M USD +68.5%
Net Cash Provided by (Used in) Investing Activities -2.92B USD +49.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 99.6M shares +0.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.01B USD +58.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.28B USD -70.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.35M USD +381%
Deferred Tax Assets, Valuation Allowance 101M USD +494%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.25 pure 0%
Operating Lease, Liability 45.1M USD -23%
Depreciation 140M USD -8.68%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -207M USD +48.3%
Lessee, Operating Lease, Liability, to be Paid 55.8M USD -42.4%
Property, Plant and Equipment, Gross 1.46B USD +15.7%
Operating Lease, Liability, Current 5.81M USD -3.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.04M USD -45.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.02M USD -26.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 76.3M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.7M USD -72%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.96M USD -34.8%
Preferred Stock, Shares Issued 14.6M shares 0%
Current Income Tax Expense (Benefit) 29M USD +44.1%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.22M USD -32.3%
Operating Lease, Payments 7.96M USD -43.1%
Preferred Stock, Shares Outstanding 14.6M shares 0%
Amortization of Intangible Assets 2.05M USD +99.2%
Share-based Payment Arrangement, Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%